Mobizox contains three medicines: diclofenac, paracetamol and chlorzoxazone. Since this product had caused reactions in the past and the doctor was duly informed of this past history, it was negligent on his part to administer the same to the patient. Allergic reaction to Mobizox can be fatal. There is very little doubt that the patient died due to severe allergic reaction (rashes, low BP, low platelet count etc.) and lack of urgent treatment to deal with the situation. It may be mentioned here that a combination of these three medicines viz. diclofenac, chlorzoxazone and paracetamol is not permitted in any advanced country such as United States, Britain, Australia, Japan etc. Even in India, the drug is not only scientifically irrational but also unlawful since it is not approved by the Drugs Controller General, India (DCGI), Ministry of Health and Government of India. Mobizox appears at serial number 444 of the list of illegal combinations circulated by DCGI. Interestingly, the manufacturer Ranbaxy (owned by the Japanese) is selling this drug in India while it is not permitted to do so in its home country, Japan. Thus attending doctor, Ranbaxy and the DCGI are all answerable and responsible for the most tragic death of a young patient in the prime of her life.